NYSE : TMO
-$7.19 (-1.27%)
3.99%
795
change: -1860 | last: 2655339
change: -790 | last: 1129343
change: -763 | last: 110656
change: -106 | last: 1621852
change: 1570 | last: 282-
-
0.00
change: -140.0518 | last: 1.40057.23B
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-04-30 | Vanguard Capital Management | 28.01M | 7.53% |
| 2026-03-27 | The Vanguard Group | - | 0.00% |
| 2022-02-10 | The Vanguard Group - 23-1945930 | 31.1M | 7.89% |
| 2022-02-01 | (1) BlackRock, Inc. | 30.98M | 7.90% |
| 2021-12-20 | Eagle Holding Company II, LLC | 17.38M | 15.20% |
| 2021-12-20 | Pharmaceutical Product Development, LLC | 17.38M | 15.20% |
| 2021-12-20 | Thermo Fisher Scientific Powder US Holdings Corp. | 17.38M | 15.20% |
| 2021-12-20 | PPD, Inc. | 17.38M | 15.20% |
| 2021-12-20 | Wildcat Acquisition Holdings (UK) Limited | 17.38M | 15.20% |
| 2021-12-20 | Thermo Fisher Scientific Inc. | 17.38M | 15.20% |
| 2021-12-20 | Jaguar Holding Company II | 17.38M | 15.20% |
| 2021-12-20 | Jaguar Holding Company I, LLC | 17.38M | 15.20% |
| 2021-02-10 | The Vanguard Group - 23-1945930 | 31M | 7.82% |
| 2021-02-01 | (1) BlackRock, Inc. | 29.5M | 7.40% |
| 2020-02-12 | The Vanguard Group - 23-1945930 | 31.19M | 7.77% |
| 2020-02-06 | (1) BlackRock, Inc. | 28.2M | 7.00% |
| 2019-02-13 | 04-2747644 | 18.72M | 4.60% |
| 2019-02-06 | (1) BlackRock, Inc. | 26.18M | 6.50% |
| 2018-02-09 | 04-2747644 | 25.35M | 6.30% |
| 2018-01-23 | (1) BlackRock, Inc. | 24.15M | 6.00% |
| 2017-02-07 | 52-0556948 | 17.23M | 4.30% |
| 2017-01-27 | (1) BlackRock, Inc. | 23.01M | 5.80% |
| 2016-01-27 | (1) BlackRock, Inc. | 22.66M | 5.70% |
| 2015-02-02 | (1) BlackRock, Inc. | 23.27M | 5.80% |
| 2014-01-30 | (1) BlackRock, Inc. | 20.14M | 5.60% |
| 2011-02-09 | (1) BlackRock, Inc. | 23.32M | 5.87% |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $579.45 | 376M | $217.87B | $9.86B | $40.86B | $248.87B |
| 2024-12-31 | $520.23 | 382M | $198.73B | $4.02B | $32.78B | $227.48B |
| 2023-12-31 | $530.79 | 386M | $204.88B | $8.08B | $36.42B | $233.23B |
| 2022-12-31 | $550.69 | 392M | $215.87B | $8.52B | $36.07B | $243.42B |
| 2021-12-31 | $667.24 | 394M | $262.89B | $4.48B | $36.34B | $294.75B |
| 2020-12-31 | $465.78 | 396M | $184.45B | $10.32B | $22.54B | $196.67B |
| 2019-12-31 | $324.87 | 400M | $129.95B | $2.4B | $18.49B | $146.04B |
| 2018-12-31 | $223.79 | 402M | $89.96B | $2.1B | $18.99B | $106.85B |
| 2017-12-31 | $189.88 | 395M | $75B | $1.34B | $21.01B | $94.68B |
| 2016-12-31 | $141.10 | 394.8M | $55.71B | $786M | $16.63B | $71.55B |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-27 | $513.03 | 371M | $190.33B | $4.06B | $42.55B | $228.82B |
| 2026-03-28 | $473.36 | 372M | $176.09B | $3.25B | $43.16B | $216B |
| 2025-12-31 | $579.45 | 376M | $217.87B | $9.86B | $40.86B | $248.87B |
| 2025-09-27 | $464.24 | 378M | $175.48B | $1.98B | $35.68B | $209.18B |
| 2025-06-28 | $408.28 | 378M | $154.33B | $4.58B | $35.23B | $184.98B |
| 2025-03-29 | $500.16 | 378M | $189.06B | $4.13B | $34.19B | $219.12B |
| 2024-12-31 | $520.23 | 382.85M | $199.17B | $4.02B | $32.78B | $227.92B |
| 2024-09-28 | $614.42 | 382M | $234.71B | $4.64B | $35.31B | $265.38B |
| 2024-06-29 | $553.00 | 382M | $211.25B | $7.08B | $35.4B | $239.57B |
| 2024-03-30 | $581.21 | 382M | $222.02B | $5.51B | $35.61B | $252.12B |
| 2023-12-31 | $530.79 | 387M | $205.42B | $8.08B | $36.42B | $233.76B |
| 2023-09-30 | $506.17 | 386M | $195.38B | $6.15B | $35.28B | $224.51B |